-
Document de presse | 2014.08.27
Potential strategies for limiting the hepatitis C epidemic in Egypt
In the fight against hepatitis C, directing preventive and curative interventions towards sufferers of chronic diseases requiring regular medical care would be an effective means of reducing transmission of the hepatitis C virus (HCV) in Egypt, and undoubtedly also in other countries with limited resources. This theory has arisen from a mathematical modeling study carried out as part of the ANRS...
-
Document de presse | 2014.09.01
Mental states control the integration of new neurons in the adult brain
Although it has been known for several years that the adult brain is capable of producing new neurons, how these neurons are integrated into existing, functional nerve circuits has hitherto remained a mystery. Scientists at the Institut Pasteur and the CNRS have just shown that new neurons set up a denser network of connections with the rest of the brain in contexts of active (as opposed to...
-
Document de presse | 2014.09.09
Highly regulated therapeutic target shows promise in the search for new antimalarial treatments
Artemisinin is currently the most effective malarial treatment available. However, the recent emergence in South-East Asia of artemisinin-resistant parasites strengthens the urgent need to identify a new generation of antimalarial drugs. In this context, scientists at the Institut Pasteur and CNRS have determined the three-dimensional structure of a promising new therapeutic target for malaria:...
-
News | 2014.09.23
MOU between Institut Pasteur and Fondation Mérieux in response to the Ebola virus and other hemorrhagic fever disease in Western Africa
Fondation Mérieux and Institut Pasteur signed September 12, 2014 a Memorandum of Understanding (MOU). This MOU serves to set forth the areas of collaboration in response to the Ebola virus disease (EVD) and other hemorrhagic fever diseases in Western Africa through three ways: Deployment of a new mobile laboratory, dedicated to detection and identification of infectious diseases caused by risk...
-
Document de presse | 2014.11.26
Ebola: a new Institut Pasteur is soon to be created in Guinea
Pr Christian Bréchot, President of the Institut Pasteur, will be in Guinea Friday 28th November 2014, alongside François Hollande, President of the French Republic. Two agreements will be signed, one with the government of Guinea and the other one with the French Agency for Development (AFD), allowing for the creation of a new Pasteur Institute in Conakry in late 2016. On Saturday 29th, Pr....
-
Document de presse | 2015.01.13
Identification of an Achilles heel in the dengue virus gives new hope for vaccine development
In association with Imperial College London, scientists at the Institut Pasteur and CNRS have identified a vulnerable site on the surface of the dengue virus which is targeted by the only broadly neutralizing antibodies identified to date. This discovery offers a new target for the development of a vaccine to combat all four types of dengue virus currently in circulation. These results were...
-
News | 2015.01.13
Identification of an Achilles heel in the dengue virus gives new hope for vaccine development
Scientists have identified a vulnerable site on the surface of the dengue virus which is targeted by the only broadly neutralizing antibodies identified to date. This discovery offers a new target for the development of a vaccine to combat all four types of dengue virus currently in circulation.
-
Fiche maladie | 2015.10.06
Group A and B Streptococcus
Infections with group A and B Streptococcus (respectively Streptococcus pyogenes and Streptococcus agalactiae) are frequent. The two bacteria are part of the commensal flora; they are opportunistic pathogens and only cause symptoms in certain conditions or in people at risk. Group A Streptococcus (also known as GAS or Strep A) is responsible for several benign infections but can also cause...
-
Fiche maladie | 2015.10.06
Candidiasis
Fungi (yeast) of the Candida genus can cause superficial infections affecting the mucous membranes or skin, and invasive infections, either localized to one organ or generalized throughout the body. Of the 200 known species of Candida, around twenty are responsible for human infection. Candida yeasts are often responsible for severe, hospital-acquired infections.
-
Document de presse | 2015.10.28
The Institut Pasteur and Chan Soon-Shiong Institute for Molecular Medicine Partner to Form Global Genomics Center
Paris, France and Los Angeles, CaliforniaThe Chan Soon-Shiong Institute for Molecular Medicine (CSSIOMM) and the Institut Pasteur today announced a partnership to establish The Pasteur Global Health Genomics Center (PGHGC). The aim of the PGHGC is to advance genomic research utilizing next-generation patient information systems needed to support the acquisition and usage of high-quality...